TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - TEVA PHARMACEUTICAL INDUSTRIES Share Price

Certificat

DE000SW7JN16

Real-time Boerse Frankfurt Warrants 06:36:18 20/05/2024 pm IST
9.99 EUR -0.89% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - TEVA PHARMACEUTICAL INDUSTRIES
Current month-18.25%
1 month-23.58%
Date Price Change
20/24/20 9.99 -0.89%
17/24/17 10.08 -0.40%
16/24/16 10.12 +4.44%
15/24/15 9.69 +2.43%
14/24/14 9.46 -1.77%

Real-time Boerse Frankfurt Warrants

Last update May 20, 2024 at 06:36 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
IssuerLogo Issuer Société Générale Société Générale
WKN SW7JN1
ISINDE000SW7JN16
Date issued 11/03/2024
Strike 27.16 $
Maturity Unlimited
Parity 1 : 1
Emission price 12.38
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 13.86
Lowest since issue 9.26
Spread 0.21
Spread %2.06%

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
16.29 USD
Average target price
17.34 USD
Spread / Average Target
+6.42%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW